Bosco Barón Franco (Spain)

Hospital Universitario Virgen del Rocio Internal Medicine

Author of 1 Presentation

BIOCONSTANTS IN THE MEDICAL OFFICE VERSUS HOME TELEMONITORING DEVICES. ATLAN_TIC PROJECT.

Date
Fri, 19.03.2021
Session Time
10:00 - 11:00
Room
Hall C
Lecture Time
10:14 - 10:21

Abstract

Background and Aims

To analyze the control of bioconstants measured in the medical office versus telemonitoring in a clinical trial, in patients with advanced cardiac and/or respiratory failure.

Methods

Multicenter clinical trial including patients with heart failure with NYHA≥III and/or chronic respiratory failure with MRC≥III and/or oxygen saturation<90% and/or oxygen therapy. Randomization in PAC Arm (optimal standard of clinical care) and TELEPAC Arm (addition of constant telemonitoring equipment) to evaluate the requirements of hospitalization and emergency visits. Follow-up of 180 days. Secondary analysis of the control of bioconstants in medical office versus telemonitoring. A calibration was performed between the consultation and telemonitoring devices with a variability <5%.SSPSv20 statistical package. Approved by the Research Ethics Committee.

Results

510 patients from 5 hospitals were included, 255 patients in each arm. Median age was 76,5 years, being 54.5% females. Cardiac inclusion criteria were presented for 321 patients (63.1%), respiratory 71(13.9%) and 117(22.9%) both criteria. No differences were found in hospital admissions or emergency room visits. The median values of the biocostants measured in the medical office were: systolic blood pressure 126.77+/-30.93mmHg; diastolic blood pressure 68.53+/-8.83mmHg; heart rate 75.38+/-10.07 bpm; O2 saturation 94.82+/-2.82%; weight 79.55+/-18.47Kg. The average values of the biocostants measured with telemonitoring devices were: systolic blood pressure 120.72+/-18.63mmHg; diastolic blood pressure 68+/-9.50mmHg; heart rate 75.89+/-11.0 beats per minute; O2 saturation 93.92+/-3.48%; weight 77.69+/-19.39Kg. Differences were found in mean systolic blood pressure (PAC 126.77+/-30.93mmHg, TELEPAC 120.72+/- 8.63mmHg, p <0.05).

Conclusions

There was an adequate control of bioconstants. No differences were found in the face-to-face consultations versus telemonitoring except for systolic blood pressure.

Hide